Rehabilitation Science

Quadriceps and Knee Surgery

The muscle that determines the outcome of your surgery. Arthrogenic muscle inhibition (AMI) is more common than people think — and it is treatable.

Book a Consultation

The Most Important Muscle in the Knee

The quadriceps femoris — the muscle group on the front of the thigh — is the main active stabiliser of the knee. Its recovery after injury or surgery is decisive for the short- and long-term clinical outcome.

Understanding its anatomy, function and the mechanisms that can inhibit its activation is essential for any patient facing knee surgery.

An inhibited quadriceps before surgery is an independent risk factor for postoperative arthrofibrosis. In selected cases, surgery should be postponed until the AMI has resolved.

Quadriceps Anatomy

RECTUS FEMORIS V. LAT. V. MED. PATELLA PATELLAR TEND. VMO ★ AMI Rectus Femoris V. Lateralis V. Medialis VMO (AMI target)

The Four Components of the Quadriceps

1

Rectus Femoris

Located on the front of the thigh. The only biarticular muscle — it acts on both the knee and the hip. The main extensor of the knee.

Knee extension + hip flexion
2

Vastus Lateralis

Located on the outer side of the thigh. Contributes to knee extension and lateral stability of the patella.

Extension + lateral stability
3

Vastus Medialis (VMO)

On the inner side of the thigh. The VMO is particularly vulnerable to arthrogenic inhibition and decisive for patellar alignment.

Main AMI target
4

Vastus Intermedius

Deep, between the vastus lateralis and medialis. Contributes to the even distribution of the extension force.

Force distribution

Arthrogenic Muscle Inhibition (AMI)

⚠ What AMI is and why it matters

AMI is a neurological — not muscular — phenomenon in which the ability of the quadriceps to contract and generate force becomes impaired after knee injury or surgery. The cause is not muscle weakness: it is inhibition via the neural pathway, mediated by altered articular afferent input that reduces the excitability of the α-motor neurons.

For decades, orthopaedic rehabilitation blamed pain, fear or "weakness" for deficient knee extension. We now know that AMI is a centralised protective reflex that inhibits the VMO after joint trauma — and that ignoring it preoperatively is an independent risk factor for arthrofibrosis.

AMI can manifest in several ways: isolated inhibition of the VMO, an extension deficit due to hamstring contracture, or a chronic extension deficit. The work of the team led by Prof. Bertrand Sonnery-Cottet (Centre Orthopédique Santy, Lyon) established the first systematic clinical classification.

Classification by Sonnery-Cottet et al.

The SANTI classification for AMI after knee injury or surgery — with excellent inter- and intra-observer reliability, validated in 2025 — makes it possible to stratify risk and guide clinical decision-making, including possible postponement of surgery.

Grade Designation Clinical Presentation Management
Grade 0 Normal Normal quadriceps function; no active extension deficit Proceed with surgery
Grade 1a Mild Inhibition — Reversible VMO inhibition reversible within minutes after simple active-assisted extension exercises Short pre-op rehabilitation; surgery possible
Grade 1b Mild Inhibition — Persistent VMO inhibition resistant to simple exercises; requires more prolonged rehabilitation programmes Targeted rehabilitation programme before surgery
Grade 2a Inhibition + Extension Deficit (Reversible) VMO inhibition with an extension deficit due to hamstring contracture; reversible with simple exercises Specific rehabilitation; consider postponing surgery
Grade 2b Inhibition + Extension Deficit (Refractory) Resistant to simple exercises; requires long, specific rehabilitation programmes Postpone surgery — intensive neuromotor rehabilitation
Grade 3 Chronic Irreducible Deficit Chronic extension deficit not correctable without extensive posterior arthrolysis Specific surgical intervention (arthrolysis)
Clinical note: Failing to consider AMI preoperatively is associated with a very high risk of postoperative joint stiffness. Identifying at-risk patients is essential to optimise outcomes and avoid complications such as arthrofibrosis.

How Is AMI Treated?

The available therapeutic interventions have variable efficacy. Current evidence is of low to moderate quality for most modalities — which underlines the importance of specialist centres.

Neuromuscular Electrical Stimulation (NMES)

Transcutaneous electrical stimulation of the quadriceps to overcome neural inhibition and recruit motor units. Can be combined with EMG biofeedback.

Moderate evidence

Neuromotor Reprogramming (RNR)

An innovative protocol based on proprioceptive sensations, motor imagery and low-frequency sounds. Developed at the Centre Orthopédique Santy (Lyon).

Emerging evidence

Cryotherapy

Applying cold reduces the inhibitory effect of joint effusion on the quadriceps. Most effective when combined with exercise.

Moderate evidence

Eccentric Exercise

Eccentric loading of the quadriceps with careful progression. Contraction-to-failure technique improves voluntary activation of the muscle.

Good evidence

EMG Biofeedback

Real-time feedback of muscle electrical activity allows the patient to learn to recruit the VMO effectively.

Moderate evidence

Transcranial Magnetic Stimulation

Modulation of motor cortical excitability. An emerging technique with promising results in patients with refractory AMI.

Active research
NC

Dr. Nuno Camelo Barbosa

Orthopaedic Surgeon · Knee Subspecialist
Hospital Lusíadas Porto · Hospital Misericórdia Vila do Conde · Paços de Ferreira

QuadricepsAMINeuromuscular rehab

Do you have a knee extension deficit?

AMI is underestimated and underdiagnosed. A specialist assessment can change the treatment plan — and the outcome of surgery.

Book an Appointment 926 850 194

In Consultation

Quadriceps activation